Skip to main content

RET Research News and Information

Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.

The Happy Lungs Project Update: July 2024
RET positive lung cancer support
The Happy Lungs Project Update: July 2024

The Happy Lungs Project Update: July 2024

Cancer drug resistance means that a tumor no longer responds to anticancer drugs that were…
July 14, 2024
American Society of Clinical Oncology Annual Meeting 2024
ASCO conference 2024
American Society of Clinical Oncology Annual Meeting 2024

American Society of Clinical Oncology Annual Meeting 2024

The 2024 ASCO Annual Meeting, held May 31-June 4 in Chicago, IL, brought together more…
June 18, 2024
Results From Our Spring 2024 Survey
RET lung cancer research survey 2024
Results From Our Spring 2024 Survey

Results From Our Spring 2024 Survey

What we learned, and what’s next: Scientific research can be confusing and overwhelming, and that’s…
May 29, 2024
IASLC Targeted Therapies Recap
together separately live stream
IASLC Targeted Therapies Recap

IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…
March 11, 2024
Looking Ahead: The Future of Diagnostic Testing for Patients
oncogene testing RET lung cancer
Looking Ahead: The Future of Diagnostic Testing for Patients

Looking Ahead: The Future of Diagnostic Testing for Patients

Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…
January 7, 2024
2023 RET Cancer Research Update
ret cancer research 2023
2023 RET Cancer Research Update

2023 RET Cancer Research Update

2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…
December 18, 2023
Exciting Preclinical Results About Vepafestinib
RET lung cancer study 2023
Exciting Preclinical Results About Vepafestinib

Exciting Preclinical Results About Vepafestinib

New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06).  Vepafestinib showed selectivity…
October 10, 2023
Two research studies funded by HLP presented at 2023 ASCO Mtg
on and off target ret resistance
Two research studies funded by HLP presented at 2023 ASCO Mtg

Two research studies funded by HLP presented at 2023 ASCO Mtg

Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…
June 19, 2023
Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors
Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors

Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors

Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…
June 19, 2023
DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies
DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…
June 19, 2023
Virtual Event: 2022 RET Cancer Research Update (Watch Video)
2022 ret cancer research update happy lungs project
Virtual Event: 2022 RET Cancer Research Update (Watch Video)

Virtual Event: 2022 RET Cancer Research Update (Watch Video)

The Happy Lungs Project hosted a 2022 Research Update, featuring presentations about advances for RET-positive…
December 13, 2022
Participants Needed: Epidemiology of Young Lung Cancer Study
lung cancer study
Participants Needed: Epidemiology of Young Lung Cancer Study

Participants Needed: Epidemiology of Young Lung Cancer Study

Epidemiology of Young Lung Cancer is a clinical study for patients who were diagnosed with…
November 29, 2022
Press Release: Happy Lungs Shopping Card Raised Thousands for Lung Cancer Research
happy lungs shopping card Austin
Press Release: Happy Lungs Shopping Card Raised Thousands for Lung Cancer Research

Press Release: Happy Lungs Shopping Card Raised Thousands for Lung Cancer Research

HAPPY LUNGS SHOPPING CARD SUCCESSFUL IN AUSTIN PREMIER, RAISING THOUSANDS FOR LUNG CANCER RESEARCH, GENERATING RETAIL…
November 15, 2022
Dr. Irene Guijarro Munoz Named Our Science Liaison & Research Manager
irene guijarro Munoz
Dr. Irene Guijarro Munoz Named Our Science Liaison & Research Manager

Dr. Irene Guijarro Munoz Named Our Science Liaison & Research Manager

Dr. Irene Guijarro Munoz has been named the Science Liaison and Research Manager for the…
September 27, 2022
Press Release: Partnering on Innovative Lung Cancer Research
2022 RET Summit lung cancer
Press Release: Partnering on Innovative Lung Cancer Research

Press Release: Partnering on Innovative Lung Cancer Research

The Happy Lungs Project is pleased to share research that we are funding in collaboration…
May 31, 2022
happy lungs project logo
The mission of The Happy Lungs Project is to save the lives of RET-positive lung cancer patients by advancing research and treatment options. 

Email: info@happylungsproject.org

Address: 3209 Sunny Ln. Austin, TX 78731

Linkedin
Tik Tok

About Us

Research

Clinical Trials

Join Us

Donate

Financials

Contact

Scientific research can be confusing and overwhelming

Get our monthly emails about RET-positive research and what it means for current treatment options and future therapies.

© 2024 Happy Lungs Project | Privacy Policy | Terms of Service | Designed by Reinhardt Designs